This content is machine translated Head and Neck Tumors New therapies Tumors of the head and neck were the seventh most common cancer worldwide in 2018. The most important risk factors include nicotine and alcohol consumption. The prognosis and multimodality treatment… CME-Test
View Post 3 min This content is machine translated HRD-positive advanced ovarian cancer. PARP inhibitor recommended for first-line maintenance therapy Poly-ADP-ribose polymerase (PARP) inhibitors have added valuable options to the therapeutic landscape in advanced ovarian cancer and have already found their way into ASCO and NCCN guidelines [1–3]. With the…
View Post 12 min This content is machine translated Malignant melanoma Adjuvant Therapy: State of the Art The annual incidence of malignant melanoma has steadily increased over the past 40 years. While the prognosis is good in the early stages, it worsens as the tumor stage increases.… CME-Test
View Post 2 min This content is machine translated Listeria monocytogenes Infectious agent offers protection against liver cancer Liver cancer is the third leading cause of cancer-related deaths worldwide. To date, treatment options for two liver cancers, hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), have been inadequate, while new…
View Post 4 min This content is machine translated Pheochromocytomas and paragangliomas Rare neuroendocrine tumors – individualized patient management is essential If a catecholamine-secreting tumor is suspected, determination of metanephrines in free plasma is a sensitive diagnostic method. Paroxysmal hypertension is a common symptom. Depending on the laboratory findings, an imaging…
View Post 4 min This content is machine translated Non-small cell lung cancer Molecular diagnostics under the microscope To date, molecular testing in non-small cell lung cancer (NSCLC) has been reserved primarily for stage IV patients. However, with the introduction of targeted therapies also in earlier tumor stages,…
View Post 4 min This content is machine translated Metastatic urothelial carcinoma of the urinary bladder Therapy in transition Despite the pandemic, this year’s Swiss Oncology and Hematology Congress (SOHC) was held face-to-face – with more than 1300 participants. Metastatic urothelial carcinoma of the urinary bladder was also a…
View Post 3 min This content is machine translated The somewhat different knowledge Cancer therapy and fingerprinting: a search for traces of lost papillary lines. Fingerprinting before entering a foreign country? Quickly unlock your smartphone using fingerprint technology? What seemed self-evident yesterday can become impossible for cancer patients within a very short time. Although the…
View Post 2 min This content is machine translated Guideline recommendations on pancreatic cancer. Minimum quantities for operations The Oncology Guideline Program has updated its S3 guideline on exocrine pancreatic cancer. The revised version contains, among other things, new recommendations on diagnostics, curative and palliative therapy of pancreatic…
View Post 6 min This content is machine translated Assisted suicide in oncology A medical task? Oncology is a discipline in which dying and death are omnipresent. Thus, assisted suicide is also a common – and controversial – topic in daily oncology practice. While this has been…
View Post 5 min This content is machine translated BRAFV600 stage IV melanoma Targeted therapy: “real world” data on encorafenib plus binimetinib The BERING-Melanoma multicenter study is monitoring the use of encorafenib with binimetinib in the first- and second-line setting* in patients with advanced BRAFV600-mutated malignant melanoma in everyday care in Germany, Austria,…
